Christopher P. Ellis

Array ( [id] => 3853250 [patent_doc_number] => 05767260 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Antigen-binding fusion proteins' [patent_app_type] => 1 [patent_app_number] => 8/515903 [patent_app_country] => US [patent_app_date] => 1995-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 22 [patent_no_of_words] => 11284 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/767/05767260.pdf [firstpage_image] =>[orig_patent_app_number] => 515903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3621559 [patent_doc_number] => 05620689 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-15 [patent_title] => 'Liposomes for treatment of B-cell and T-cell disorders' [patent_app_type] => 1 [patent_app_number] => 8/475050 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 47 [patent_no_of_words] => 13545 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/620/05620689.pdf [firstpage_image] =>[orig_patent_app_number] => 475050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3994729 [patent_doc_number] => 05892020 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Multivalent single chain antibodies' [patent_app_type] => 1 [patent_app_number] => 8/481006 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 24 [patent_no_of_words] => 9973 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/892/05892020.pdf [firstpage_image] =>[orig_patent_app_number] => 481006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3623261 [patent_doc_number] => 05688927 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-18 [patent_title] => 'Macrophage derived chemokine' [patent_app_type] => 1 [patent_app_number] => 8/480449 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11813 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/688/05688927.pdf [firstpage_image] =>[orig_patent_app_number] => 480449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3781490 [patent_doc_number] => 05736139 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-07 [patent_title] => 'Treatment of Clostridium difficile induced disease' [patent_app_type] => 1 [patent_app_number] => 8/480604 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 55 [patent_no_of_words] => 110331 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/736/05736139.pdf [firstpage_image] =>[orig_patent_app_number] => 480604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3842822 [patent_doc_number] => 05766590 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Therapeutic methods and pharmaceutical compositions' [patent_app_type] => 1 [patent_app_number] => 8/483184 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11142 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/766/05766590.pdf [firstpage_image] =>[orig_patent_app_number] => 483184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3725154 [patent_doc_number] => 05651970 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-29 [patent_title] => 'Method for inhibiting disease associated with the human immunodeficiency virus through the use of monoclonal antibodies directed against anti-self cytotoxic T-lymphocytes or their lytics' [patent_app_type] => 1 [patent_app_number] => 8/483745 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2916 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/651/05651970.pdf [firstpage_image] =>[orig_patent_app_number] => 483745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3888470 [patent_doc_number] => 05777078 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-07 [patent_title] => 'Triggered pore-forming agents' [patent_app_type] => 1 [patent_app_number] => 8/478913 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 30 [patent_no_of_words] => 15440 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/777/05777078.pdf [firstpage_image] =>[orig_patent_app_number] => 478913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3618982 [patent_doc_number] => 05601821 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-11 [patent_title] => 'Immunoactive peptides and antibodies and their use in anti-allergy treatment' [patent_app_type] => 1 [patent_app_number] => 8/480505 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 9505 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/601/05601821.pdf [firstpage_image] =>[orig_patent_app_number] => 480505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3630819 [patent_doc_number] => 05686583 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'Specific antibodies against activated platelets, the preparation thereof and the use thereof in diagnosis and therapy' [patent_app_type] => 1 [patent_app_number] => 8/467393 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 25 [patent_no_of_words] => 4405 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686583.pdf [firstpage_image] =>[orig_patent_app_number] => 467393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3831604 [patent_doc_number] => 05846535 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Methods for reducing tumor cell growth by using antibodies with broad tumor reactivity and limited normal tissue reactivity' [patent_app_type] => 1 [patent_app_number] => 8/467959 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4763 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/846/05846535.pdf [firstpage_image] =>[orig_patent_app_number] => 467959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3774630 [patent_doc_number] => 05756683 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-26 [patent_title] => 'Immunological detection method' [patent_app_type] => 1 [patent_app_number] => 8/470529 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15468 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/756/05756683.pdf [firstpage_image] =>[orig_patent_app_number] => 470529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3874744 [patent_doc_number] => 05747337 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-05 [patent_title] => 'Factor VIII coagulant polypeptides and monoclonal antibodies to them' [patent_app_type] => 1 [patent_app_number] => 8/462114 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9021 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/747/05747337.pdf [firstpage_image] =>[orig_patent_app_number] => 462114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3661522 [patent_doc_number] => 05624896 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-29 [patent_title] => 'Clearing agents useful in pretargeting methods' [patent_app_type] => 1 [patent_app_number] => 8/462765 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 34573 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/624/05624896.pdf [firstpage_image] =>[orig_patent_app_number] => 462765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3655731 [patent_doc_number] => 05658763 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-19 [patent_title] => 'Methods and compositions for high protein production from non-native DNA' [patent_app_type] => 1 [patent_app_number] => 8/463675 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13010 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 247 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/658/05658763.pdf [firstpage_image] =>[orig_patent_app_number] => 463675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3861077 [patent_doc_number] => 05792838 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-11 [patent_title] => 'Method for stabilizing immunoglobulin compositions' [patent_app_type] => 1 [patent_app_number] => 8/465319 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5099 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/792/05792838.pdf [firstpage_image] =>[orig_patent_app_number] => 465319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3733992 [patent_doc_number] => 05753204 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-19 [patent_title] => 'Biosynthetic binding proteins for immunotargeting' [patent_app_type] => 1 [patent_app_number] => 8/461838 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 15385 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 230 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/753/05753204.pdf [firstpage_image] =>[orig_patent_app_number] => 461838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3864097 [patent_doc_number] => 05762934 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Clostridium difficile toxin disease therapy' [patent_app_type] => 1 [patent_app_number] => 8/456847 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 16 [patent_no_of_words] => 27210 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/762/05762934.pdf [firstpage_image] =>[orig_patent_app_number] => 456847 [rel_patent_id] =>[rel_patent_doc_number] =>)